Across the recent three months, 6 analysts have shared their insights on Conmed (NYSE:CNMD), expressing a variety of opinions spanning from bullish to bearish.

The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.

In the assessment of 12-month price targets, analysts unveil insights for Conmed, presenting an average target of $89.5, a high estimate of $107.00, and a low estimate of $71.00. Observing a downward trend, the current average is 7.42% lower than the prior average price target of $96.67.

Investigating Analyst Ratings: An Elaborate Study

The standing...